EUVIMEDEUVIMED entdecken
StudienprotokollOpen Access · CC BY 4.0

The Dutch chronic lower limb-threatening ischemia registry (THRILLER): A study protocol for popliteal and infrapopliteal endovascular interventions

Michael J Nugteren iD, Constantijn E V B Hazenberg, George P Akkersdijk, Olaf J Bakker, Maarten K Dinkelman, Bram Fioole, Daniel A F van den Heuvel, Jan M M Heyligers, Jan-Willem Hinnen, Maurice Pierie, Olaf Schouten, Michiel A Schreve und 3 weitere

PLOS ONE · 2023

DOI: 10.1371/journal.pone.0288912 ↗

Kurz gefasst

Studienprotokoll in der Zeitschrift PLOS ONE, 2023. Verfasst von Michael J Nugteren und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Vascular Surgery, Noordwest Ziekenhuisgroep, Alkmaar, The Netherlands. Hauptthemen laut MEDLINE: Endovascular Procedures, Peripheral Arterial Disease. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Bayer, Abbott Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Chronic limb-threatening ischemia (CLTI) is the end stage of peripheral arterial disease (PAD) and is associated with high amputation rates, mortality and disease-related health care costs. In infrapopliteal arterial disease (IPAD), endovascular revascularization should be considered for the majority of anatomical and clinical subgroups of CLTI. However, a gap of high-quality evidence exists in this field. The aim of the Dutch Chronic Lower Limb-Threatening Ischemia Registry (THRILLER) is to collect real world data on popliteal and infrapopliteal endovascular interventions.

Methods

THRILLER is a clinician-driven, prospective, multicenter, observational registry including all consecutive patients that undergo a popliteal or infrapopliteal endovascular intervention in seven Dutch hospitals. We estimate that THRILLER will include 400–500 interventions annually. Standardized follow-up visits with wound monitoring, toe pressure measurement and duplex ultrasonography will be scheduled at 6–8 weeks and 12 months after the intervention. The independent primary endpoints are primary patency, limb salvage and amputation free survival. Patients must give informed consent before participation and will be included according to predefined reporting standards. A data log of patients who meet the inclusion criteria but are not included in the registry will be maintained. We intend to conduct the first interim analysis two years after the start of inclusion. The results will be published in a scientific journal.

Discussion

Despite innovations in medical therapy and revascularization techniques, patients with CLTI undergoing endovascular revascularization still have a moderate prognosis. Previous prospective cohort studies were hampered by small sample sizes or heterogeneous reporting. Randomized controlled trials (RCTs) have high costs, potential conflicts of interest and give a limited reflection of daily practice. THRILLER aims to provide the largest prospective well phenotyped up-to-date dataset on treatment outcomes in CLTI patients to answer multiple underexplored research questions regarding diagnostics, medication, patient selection, treatment strategies and post intervention follow-up.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Endovascular ProceduresPeripheral Arterial DiseaseHumansChronic DiseaseChronic Limb-Threatening IschemiaIschemiaLimb SalvageLower ExtremityMulticenter Studies as TopicRegistriesRetrospective StudiesRisk FactorsTreatment OutcomeVascular PatencyObservational Studies as Topic

Autor:innen und Institutionen

  • Department of Vascular Surgery, Noordwest Ziekenhuisgroep, Alkmaar, The Netherlands.
  • Department of Vascular Surgery, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Department of Vascular Surgery, Maasstad Ziekenhuis, Rotterdam, The Netherlands.
  • Department of Vascular Surgery, St. Antonius Ziekenhuis, Nieuwegein, The Netherlands.
  • Department of Vascular Surgery, Elisabeth-TweeSteden Ziekenhuis, Tilburg, The Netherlands.
  • Department of Radiology, St. Antonius Ziekenhuis, Nieuwegein, The Netherlands.

ORCID-Profile: Michael J Nugteren

Förderung

  • Bayer
  • Abbott Fund

Zitieren

APA

Nugteren, M. J., Hazenberg, C. E. V. B., Akkersdijk, G. P., Bakker, O. J., Dinkelman, M. K., Fioole, B., van den Heuvel, D. A. F., Heyligers, J. M. M., Hinnen, J. W., Pierie, M., Schouten, O., Schreve, M. A., Verhoeven, B. A. N., de Borst, G. J., & Ünlü, Ç. (2023). The Dutch chronic lower limb-threatening ischemia registry (THRILLER): A study protocol for popliteal and infrapopliteal endovascular interventions. PLOS ONE. https://doi.org/10.1371/journal.pone.0288912

Vancouver

Nugteren MJ, Hazenberg CEVB, Akkersdijk GP, Bakker OJ, Dinkelman MK, Fioole B, et al. The Dutch chronic lower limb-threatening ischemia registry (THRILLER): A study protocol for popliteal and infrapopliteal endovascular interventions. PLOS ONE. 2023. doi:10.1371/journal.pone.0288912

BibTeX
@article{Nugteren2023,
  author = {Nugteren, Michael J and Hazenberg, Constantijn E V B and Akkersdijk, George P and Bakker, Olaf J and Dinkelman, Maarten K and Fioole, Bram and van den Heuvel, Daniel A F and Heyligers, Jan M M and Hinnen, Jan-Willem and Pierie, Maurice and Schouten, Olaf and Schreve, Michiel A and Verhoeven, Bart A N and de Borst, Gert J and Ünlü, Çağdaş},
  title = {The Dutch chronic lower limb-threatening ischemia registry (THRILLER): A study protocol for popliteal and infrapopliteal endovascular interventions},
  journal = {PLOS ONE},
  year = {2023},
  doi = {10.1371/journal.pone.0288912}
}
Kostenlos starten →